Director HCP Medical Education & Congress Strategy Admilparant

Job description

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it. Position Summary: Admilparant (an LPA1 antagonist) is a foundational asset for Bristol Myers Squibb in pulmonology, representing a potential first-in-class treatment option for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). The Director, HCP Medical Education & Congress Strategy will be responsible for developing and executing the U.S. KOL engagement strategy, medical education programming, peer-to-peer promotional activities, and congress commercial strategy for Admilparant across the IPF and PPF indications. This role is responsible for how BMS’s pre- and post-launch disease and product education reaches external stakeholders: through the right thought leaders, at the right scientific forums, and via professionally executed promotional and educational programs that drive meaningful shifts in HCP understanding and behavior. The Director will build and manage the relationships, programs, and systems that allow BMS to show up credibly, compliantly, and consistently at the intersection of commercial education and medical influence across the IPF/PPF HCP landscape, spanning pulmonology, ILD centers, and the broader multidisciplinary care team. In partnership with Medical Affairs and the broader Admilparant HCP Marketing team, this role will be critical in identifying and activating KOLs, owning the annual congress strategy and execution, developing and managing peer-to-peer and speaker bureau programs, and building the operational infrastructure for KOL engagement ahead of launch. The Director must be able to operate in a fast-paced, launch-stage organization, with high expectations and accountability on quality of deliverables, and bring a bias for action, strong execution discipline, and a compliance-first mindset to all programs. The ability to establish strong partnerships with Medical Affairs (particularly MSLs and Home Office Medical), Market Access, Commercial colleagues, the Congress Management team, and external agencies is essential. This role supports an investigational compound and indications currently under development and not yet approved by the FDA. Key Responsibilities: Develop and own the annual U.S. KOL engagement plan for Admilparant across IPF and PPF, including identification and tiered prioritization of national, regional, and local thought leaders across the multi-specialty HCP landscape (pulmonologists, ILD specialists, and the broader multidisciplinary care team, including NPs/PAs) Build and manage trusted, long-term relationships with priority KOLs and emerging thought leaders at academic ILD centers, positioning BMS as a credible, science-forward partner introducing a differentiated, first-in-class mechanism to the fibrotic lung disease treatment landscape Partner closely with MSLs and Medical Directors to ensure commercial and medical KOL engagement is coordinated, clearly delineated, compliant, and mutually reinforcing — maximizing the collective impact of BMS’s external scientific engagement Plan and execute commercial KOL programs, including advisory boards, promotional speaker development, and peer-to-peer educational events — ensuring timely insight capture and actionable readouts that inform strategy Develop and maintain a KOL governance model, including goal-setting, tracking, and performance evaluation for KOL engagement activities Congress Planning & Execution Own the end-to-end U.S. commercial congress strategy and execution for Admilparant across IPF and PPF, spanning pre-launch and post-launch timeframes, anchored by ATS International Conference and CHEST Annual Meeting, and encompassing academic ILD center symposia and other priority pharmacy- and APP-focused venues Define and execute BMS’s commercial presence, messaging objectives, booth strategy, and HCP engagement activations at priority congresses, aligned to brand positioning and the evolving competitive and scientific landscape Partner with Medical Affairs colleagues on symposia, CME programming, and scientific presentations to ensure commercial and medical objectives are integrated and mutually reinforcing at key congresses Manage all congress-related commercial logistics, vendor relationships, and activities on time, on budget, and in full compliance with BMS policies and applicable regulatory requirements, in partnership with the Congress Excellence team Collaborate with the brand’s competitive intelligence team to capture and synthesize insights from congress interactions — including late-breaking clinical data — and ensure they are fed back systematically into brand strategy and planning cycles Medical Education & Professional Promotion Develop and manage the professional promotional medical education strategy for Admilparant, including peer-to-peer programs, speaker bureau development and management, and HCP-facing educational content Oversee the development, review, and deployment of promotional and educational materials for KOL engagement, speaker programs, and congress activations — ensuring scientific accuracy, message consistency, and full compliance with promotional review (MLR) requirements Identify opportunities to leverage medical education platforms (e.g., symposia, speaker programs) as vehicles for HCP behavioral change aligned to the brand’s pre-launch objectives Manage agency and vendor relationships for medical education execution, including budget oversight, scope management, and performance accountability Field Insights Generation & Advisory Board Management Capture, synthesize, and report field and KOL insights into clear, actionable brand recommendations that help solve brand problems and inform strategy and planning Coordinate advisory boards end-to-end, including strategy and planning, logistics and operations, content development, and legal/compliance review Coordinate insights sprints with field teams to address specific business questions, in partnership with brand leadership Serve as a direct point of contact with HCPs and KOLs to stay current on emerging field and market insights Maintain a structured process for tracking and disseminating insights so that sprint- and program-level learnings are accessible to the broader Admilparant team and inform strategy and executional plans Cross-Functional Collaboration & Operational Excellence Collaborate effectively with Medical Affairs, Market Access, Commercial Operations, Launch Excellence, CASA, Global Commercial, and Legal/Regulatory/Compliance to ensure KOL and Med Ed programs are fully aligned and executed with excellence Contribute to brand planning processes by providing insights from KOL interactions, congress activity, and medical education programming Establish a working cadence with cross-functional partners to drive execution, manage program dependencies, and integrate field and market insights into brand strategy and optimization Own program budgets and forecasting for KOL engagement, congress, and medical education workstreams — ensuring on-time delivery, financial accountability, and execution in full compliance with company policies and applicable regulatory requirements Build a positive, collaborative, and high-performance team environment consistent with BMS Values. Key Qualifications & Experience: BA/BS required; MBA or graduate degree preferred Minimum 8 years of progressive pharmaceutical and/or biopharmaceutical commercial experience, including demonstrated experien